SERTEL, E. Et Al. 2023. Could soluble L1 cell adhesion molecule (sL1CAM) in serum be a new biomarker for endometrial cancer?. Ginekologia polska , vol.94, no.6 , 463-469.

SERTEL, E., Demir, M., DOĞAN, S., & ÇORAKÇI, A., (2023). Could soluble L1 cell adhesion molecule (sL1CAM) in serum be a new biomarker for endometrial cancer?. Ginekologia polska , vol.94, no.6, 463-469.

SERTEL, EMRE Et Al. "Could soluble L1 cell adhesion molecule (sL1CAM) in serum be a new biomarker for endometrial cancer?," Ginekologia polska , vol.94, no.6, 463-469, 2023

SERTEL, EMRE Et Al. "Could soluble L1 cell adhesion molecule (sL1CAM) in serum be a new biomarker for endometrial cancer?." Ginekologia polska , vol.94, no.6, pp.463-469, 2023

SERTEL, E. Et Al. (2023) . "Could soluble L1 cell adhesion molecule (sL1CAM) in serum be a new biomarker for endometrial cancer?." Ginekologia polska , vol.94, no.6, pp.463-469.

@article{article, author={EMRE SERTEL Et Al. }, title={Could soluble L1 cell adhesion molecule (sL1CAM) in serum be a new biomarker for endometrial cancer?}, journal={Ginekologia polska}, year=2023, pages={463-469} }